Fast Five Quiz: Breast Cancer Presentation and Diagnosis

Pavani Chalasani, MD, MPH


July 13, 2021

According to the American Society of Clinical Oncology and the National Comprehensive Cancer Network, sentinel lymph node biopsy may be offered to the following patients:

  • Women with ductal carcinoma in situ who will be undergoing mastectomy

  • Women who previously underwent breast and/or axillary surgery

  • Women with operable breast cancer and multicentric tumors

  • Women who received preoperative/neoadjuvant systemic therapy

The European Society for Medical Oncology considers sentinel lymph node biopsy vs full axillary nodal clearance to be the standard of care in patients with primary breast cancer. Sentinel lymph node biopsy can be considered in patients who have received neoadjuvant systemic therapy if the axillary lymph node is negative.

Learn more about evaluating lymph node involvement in breast cancer.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: